88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


NUS scientists harness magnetic pulses to reprogram immune cells to fight breast cancer An innovative approach for breast cancer treatment uses localised and non-invasive pulsed electromagnetic fields to reprogram immune cells, turning them from tumour helpers to cancer killers ... 2026-09-14T Education Health Care/Hospital Higher Education Medical/Pharmaceuticals
Tomonari Abe, President of Abe Yoando Pharma, Selected as First Japanese Speaker at Longevity Investors Conference 2026 in Switzerland - Head of 295-year-old Japanese Pharmaceutical Pioneer to Present Asia's Longevity Growth Strategies and Bioscientific Research Initiatives at Prestigious Conference - ... 2026-09-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Publishes Preclinical Research Paper on CD73 Small Molecule Inhibitor ATG-037 Combined with Selinexor in Cancer Gene Therapy SHANGHAI and HONG KONG , Sept. 14, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated ... 2026-09-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Accro Bioscience Announces Inclusion of AC-101 tablets in the NMPA CDE's "Caring Plan-Extension" Pilot Program for Rare Disease Drug Development NEW YORK and SUZHOU, China , Sept. 14, 2026 /PRNewswire/ -- On September 14, 2026 (China Standard Time, UTC+8), Accro Bioscience announced tha t AC-101 tablets have been included in the Rare Diseases ... 2026-09-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
FDA Approves Telix's Brain Cancer Imaging Drug Pixclara Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer). Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma ... 2026-09-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ivonescimab Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC: Positive Overall Survival Results from HARMONi-2 Presented at WCLC 2026 HONG KONG , Sept. 13, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced the presentation of positive overall survival (OS) results from the randomized, double-blind, multicenter, registrational ... 2026-09-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
THE GALIEN FOUNDATION ANNOUNCES INAUGURAL PRIX GALIEN JAPAN FORUM & AWARDS CEREMONY Prestigious Life Sciences Platform and Awards Launch in Tokyo to Celebrate Breakthrough Innovation ... 2026-09-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Dr Hanan H. Balkhy Launches Candidacy for WHO Director-General, Pledges "A WHO the World Can Count On" Nominated by the Kingdom of Saudi Arabia A physician trained in Saudi Arabia and the United States, with more than 30 years of experience spanning clinical medicine, academic research and international ... 2026-09-10T Health Care/Hospital Infectious Disease Control Medical Equipment Medical/Pharmaceuticals
POMDOCTOR LIMITED to Participate in H.C. Wainwright's 28th Annual Global Investment Conference Virtual company presentation will be available beginning September 11, 2026, at 7:00 a.m. ET ... 2026-09-10T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals Trade show news
ZEISS announces commercial availability of bitoric hydrophobic monofocal IOL - the ZEISS AT LUCIA toric 721P Launching at ESCRS in London, the world's first bitoric hydrophobic monofocal intraocular lens with a non-constant asphericity profile design expands the ZEISS LUCIA Family to treat cataracts while simultaneously ... 2026-09-10T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals